{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T06:37:52Z","timestamp":1794638272301,"version":"4.9.1"},"reference-count":247,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100008460","name":"National Center for Complementary and Integrative Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008460","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 AT007003"],"award-info":[{"award-number":["R01 AT007003"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Progress in Lipid Research"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1016\/j.plipres.2023.101242","type":"journal-article","created":{"date-parts":[[2023,8,18]],"date-time":"2023-08-18T06:18:45Z","timestamp":1692339525000},"page":"101242","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":40,"special_numbering":"C","title":["FADS2 function at the major cancer hotspot 11q13 locus alters fatty acid metabolism in cancer"],"prefix":"10.1016","volume":"92","author":[{"given":"Kumar S.D.","family":"Kothapalli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui Gyu","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niharika S.L.","family":"Kothapalli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Thomas","family":"Brenna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.plipres.2023.101242_bb0005","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3322\/caac.21654","article-title":"Cancer Statistics, 2021","volume":"71","author":"Siegel","year":"2021","journal-title":"CA Cancer J. Clin."},{"issue":"3","key":"10.1016\/j.plipres.2023.101242_bb0010","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3322\/caac.21660","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J. Clin."},{"issue":"D1","key":"10.1016\/j.plipres.2023.101242_bb0015","doi-asserted-by":"crossref","first-page":"D941","DOI":"10.1093\/nar\/gky1015","article-title":"COSMIC: the Catalogue Of Somatic Mutations In Cancer","volume":"47","author":"Tate","year":"2019","journal-title":"Nucleic Acids Res."},{"issue":"1","key":"10.1016\/j.plipres.2023.101242_bb0020","doi-asserted-by":"crossref","first-page":"2438","DOI":"10.1038\/s41467-020-16293-7","article-title":"Germline variant burden in cancer genes correlates with age at diagnosis and somatic mutation burden","volume":"11","author":"Qing","year":"2020","journal-title":"Nat. Commun."},{"issue":"10","key":"10.1016\/j.plipres.2023.101242_bb0025","doi-asserted-by":"crossref","first-page":"2457","DOI":"10.1158\/0008-5472.CAN-11-2612","article-title":"A comprehensive survey of Ras mutations in cancer","volume":"72","author":"Prior","year":"2012","journal-title":"Cancer Res."},{"issue":"67","key":"10.1016\/j.plipres.2023.101242_bb0030","doi-asserted-by":"crossref","first-page":"111246","DOI":"10.18632\/oncotarget.22768","article-title":"Molecular characteristics and clinical outcomes of EGFR exon 19 indel subtypes to EGFR TKIs in NSCLC patients","volume":"8","author":"Su","year":"2017","journal-title":"Oncotarget"},{"issue":"1","key":"10.1016\/j.plipres.2023.101242_bb0035","doi-asserted-by":"crossref","first-page":"18722","DOI":"10.1038\/s41598-019-54286-9","article-title":"Genomic Landscape of Intramedullary Spinal Cord Gliomas","volume":"9","author":"Zhang","year":"2019","journal-title":"Sci. Rep."},{"issue":"10","key":"10.1016\/j.plipres.2023.101242_bb0040","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1038\/nrc2230","article-title":"Genetic and molecular pathogenesis of mantle cell lymphoma: perspectives for new targeted therapeutics","volume":"7","author":"Jares","year":"2007","journal-title":"Nat. Rev. Cancer"},{"issue":"3","key":"10.1016\/j.plipres.2023.101242_bb0045","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1002\/ajh.25011","article-title":"Chronic myeloid leukemia: 2018 update on diagnosis, therapy and monitoring","volume":"93","author":"Jabbour","year":"2018","journal-title":"Am. J. Hematol."},{"issue":"1","key":"10.1016\/j.plipres.2023.101242_bb0050","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0304-3835(03)00419-1","article-title":"Common malignancy-associated regions of transcriptional activation (MARTA) in human prostate, breast, ovarian, and colon cancers are targets for DNA amplification","volume":"201","author":"Glinsky","year":"2003","journal-title":"Cancer Lett."},{"issue":"36","key":"10.1016\/j.plipres.2023.101242_bb0055","doi-asserted-by":"crossref","first-page":"5631","DOI":"10.1038\/sj.onc.1205698","article-title":"Localization of deletion to a 300 Kb interval of chromosome 11q13 in cervical cancer","volume":"21","author":"Srivatsan","year":"2002","journal-title":"Oncogene"},{"issue":"15","key":"10.1016\/j.plipres.2023.101242_bb0060","first-page":"4044","article-title":"Aberrant methylation of the Cyclooxygenase 2 CpG island in colorectal tumors","volume":"60","author":"Toyota","year":"2000","journal-title":"Cancer Res."},{"issue":"8","key":"10.1016\/j.plipres.2023.101242_bb0065","first-page":"1966","article-title":"Tissue microarrays for gene amplification surveys in many different tumor types","volume":"5","author":"Schraml","year":"1999","journal-title":"Clin. Cancer Res."},{"issue":"7","key":"10.1016\/j.plipres.2023.101242_bb0070","first-page":"1353","article-title":"Amplification, expression, and steroid regulation of the preprogalanin gene in human breast cancer","volume":"58","author":"Ormandy","year":"1998","journal-title":"Cancer Res."},{"issue":"6","key":"10.1016\/j.plipres.2023.101242_bb0075","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1002\/gcc.20549","article-title":"Amplification of 11q13 in ovarian carcinoma","volume":"47","author":"Brown","year":"2008","journal-title":"Genes Chromosom. Cancer"},{"key":"10.1016\/j.plipres.2023.101242_bb0080","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.oraloncology.2017.04.016","article-title":"Relevance of chromosomal band 11q13 in oral carcinogenesis: An update of current knowledge","volume":"72","author":"Ramos-Garcia","year":"2017","journal-title":"Oral Oncol."},{"issue":"1","key":"10.1016\/j.plipres.2023.101242_bb0085","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/nrc2982","article-title":"The molecular biology of head and neck cancer","volume":"11","author":"Leemans","year":"2011","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.plipres.2023.101242_bb0090","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.humpath.2018.10.017","article-title":"Amplicons in breast cancers analyzed by multiplex ligation-dependent probe amplification and fluorescence in situ hybridization","volume":"85","author":"Ooi","year":"2019","journal-title":"Hum. Pathol."},{"key":"10.1016\/j.plipres.2023.101242_bb0095","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.oraloncology.2018.06.010","article-title":"Oncogenic drivers in 11q13 associated with prognosis and response to therapy in advanced oropharyngeal carcinomas","volume":"83","author":"Barros-Filho","year":"2018","journal-title":"Oral Oncol."},{"issue":"Suppl. 15","key":"10.1016\/j.plipres.2023.101242_bb0100","doi-asserted-by":"crossref","first-page":"4036","DOI":"10.1200\/JCO.2019.37.15_suppl.4036","article-title":"Association of frequent amplification of chromosome 11q13 in esophageal squamous cell cancer with clinical benefit to immune check point blockad","volume":"37","author":"Wang","year":"2019","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.plipres.2023.101242_bb0105","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.813732","article-title":"EGFR Mutation and 11q13 Amplification Are Potential Predictive Biomarkers for Immunotherapy in Head and Neck Squamous Cell Carcinoma","volume":"13","author":"Dou","year":"2022","journal-title":"Front. Immunol."},{"issue":"16_suppl","key":"10.1016\/j.plipres.2023.101242_bb0110","doi-asserted-by":"crossref","first-page":"e16156","DOI":"10.1200\/JCO.2022.40.16_suppl.e16156","article-title":"The association of chromosome 11q13 amplification with the hyperprogressive disease in unresectable hepatocellular carcinoma patients underwent the immunotherapy","volume":"40","author":"Zhang","year":"2022","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.plipres.2023.101242_bb0115","doi-asserted-by":"crossref","first-page":"4349","DOI":"10.1158\/1538-7445.AM2018-4349","article-title":"Higher level of tumor mutational burden and 11q13 amplification in Chinese hepatocellular carcinoma patients","volume":"78","author":"Tang","year":"2018","journal-title":"Cancer Res."},{"issue":"4","key":"10.1016\/j.plipres.2023.101242_bb0120","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1177\/030089168907500404","article-title":"Genomic alterations in human breast cancer: a review","volume":"75","author":"Mariani-Costantini","year":"1989","journal-title":"Tumori"},{"issue":"1","key":"10.1016\/j.plipres.2023.101242_bb0125","first-page":"89","article-title":"The amplification unit on chromosome 11q13 in aggressive primary human breast tumors entails the bcl-1, int-2 and hst loci","volume":"4","author":"Ali","year":"1989","journal-title":"Oncogene"},{"issue":"13","key":"10.1016\/j.plipres.2023.101242_bb0130","doi-asserted-by":"crossref","first-page":"4861","DOI":"10.1073\/pnas.85.13.4861","article-title":"Human HST1 (HSTF1) gene maps to chromosome band 11q13 and coamplifies with the INT2 gene in human cancer","volume":"85","author":"Yoshida","year":"1988","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"15_suppl","key":"10.1016\/j.plipres.2023.101242_bb0135","doi-asserted-by":"crossref","first-page":"e15222","DOI":"10.1200\/JCO.2020.38.15_suppl.e15222","article-title":"The landscape of chromosome 11q13 amplification in Chinese solid tumor patients and hyperprogressive disease (HPD) clinical example","volume":"38","author":"Yu","year":"2020","journal-title":"J. Clin. Oncol."},{"issue":"10","key":"10.1016\/j.plipres.2023.101242_bb0140","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1002\/gcc.20900","article-title":"High-resolution genomic analysis of the 11q13 amplicon in breast cancers identifies synergy with 8p12 amplification, involving the mTOR targets S6K2 and 4EBP1","volume":"50","author":"Karlsson","year":"2011","journal-title":"Genes Chromosom. Cancer"},{"issue":"17","key":"10.1016\/j.plipres.2023.101242_bb0145","doi-asserted-by":"crossref","first-page":"11369","DOI":"10.1073\/pnas.172285799","article-title":"High-resolution mapping of the 11q13 amplicon and identification of a gene, TAOS1, that is amplified and overexpressed in oral cancer cells","volume":"99","author":"Huang","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"6","key":"10.1016\/j.plipres.2023.101242_bb0150","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1097\/00005537-199906000-00006","article-title":"Clinical application of fluorescence in situ hybridization for chromosome 11q13 analysis in head and neck cancer","volume":"109","author":"Alavi","year":"1999","journal-title":"Laryngoscope"},{"issue":"1","key":"10.1016\/j.plipres.2023.101242_bb0155","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0165-4608(98)00285-4","article-title":"11q13 is a cytogenetically promiscuous site in hematologic malignancies","volume":"113","author":"Wong","year":"1999","journal-title":"Cancer Genet. Cytogenet."},{"key":"10.1016\/j.plipres.2023.101242_bb0160","doi-asserted-by":"crossref","first-page":"4037","DOI":"10.2147\/IJGM.S360177","article-title":"Clinical Impact of 11q13.3 Amplification on Immune Cell Infiltration and Prognosis in Breast Cancer","volume":"15","author":"Zhou","year":"2022","journal-title":"Int. J. Gen. Med."},{"issue":"7","key":"10.1016\/j.plipres.2023.101242_bb0165","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1001\/archotol.1995.01890070076016","article-title":"Chromosome 11q13 amplification in head and neck squamous cell carcinoma. Association with poor prognosis","volume":"121","author":"Meredith","year":"1995","journal-title":"Arch. Otolaryngol. Head Neck Surg."},{"issue":"4","key":"10.1016\/j.plipres.2023.101242_bb0170","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1002\/path.1481","article-title":"High-throughput tissue microarray analysis of 11q13 gene amplification (CCND1, FGF3, FGF4, EMS1) in urinary bladder cancer","volume":"201","author":"Zaharieva","year":"2003","journal-title":"J. Pathol."},{"issue":"3","key":"10.1016\/j.plipres.2023.101242_bb0175","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1023\/A:1023033708204","article-title":"Cyclin D1, EMS1 and 11q13 amplification in breast cancer","volume":"78","author":"Ormandy","year":"2003","journal-title":"Breast Cancer Res. Treat."},{"issue":"2","key":"10.1016\/j.plipres.2023.101242_bb0180","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1007\/s10549-011-1817-3","article-title":"Characterisation of amplification patterns and target genes at chromosome 11q13 in CCND1-amplified sporadic and familial breast tumours","volume":"133","author":"Holm","year":"2012","journal-title":"Breast Cancer Res. Treat."},{"issue":"11","key":"10.1016\/j.plipres.2023.101242_bb0185","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1002\/gcc.20371","article-title":"Comprehensive genome and transcriptome analysis of the 11q13 amplicon in human oral cancer and synteny to the 7F5 amplicon in murine oral carcinoma","volume":"45","author":"Huang","year":"2006","journal-title":"Genes Chromosom. Cancer"},{"issue":"4","key":"10.1016\/j.plipres.2023.101242_bb0190","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1002\/gcc.22037","article-title":"The 11q13-q14 amplicon: clinicopathological correlations and potential drivers","volume":"52","author":"Wilkerson","year":"2013","journal-title":"Genes Chromosom. Cancer"},{"issue":"3","key":"10.1016\/j.plipres.2023.101242_bb0195","first-page":"141","article-title":"Target genes of recurrent chromosomal amplification and deletion in urothelial carcinoma","volume":"11","author":"Weilandt","year":"2014","journal-title":"Cancer Genomics Proteomics"},{"key":"10.1016\/j.plipres.2023.101242_bb0200","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1186\/1471-2407-8-297","article-title":"Amplification of HER2 is a marker for global genomic instability","volume":"8","author":"Ellsworth","year":"2008","journal-title":"BMC Cancer"},{"issue":"13","key":"10.1016\/j.plipres.2023.101242_bb0205","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.1016\/j.ejca.2010.05.013","article-title":"Lobular invasive carcinoma of the breast is a molecular entity distinct from luminal invasive ductal carcinoma","volume":"46","author":"Gruel","year":"2010","journal-title":"Eur. J. Cancer"},{"issue":"Suppl. 14","key":"10.1016\/j.plipres.2023.101242_bb0210","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1186\/s12859-020-03689-x","article-title":"Network-based method for regions with statistically frequent interchromosomal interactions at single-cell resolution","volume":"21","author":"Bulathsinghalage","year":"2020","journal-title":"BMC Bioinformat."},{"issue":"5950","key":"10.1016\/j.plipres.2023.101242_bb0215","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1126\/science.1181369","article-title":"Comprehensive mapping of long-range interactions reveals folding principles of the human genome","volume":"326","author":"Lieberman-Aiden","year":"2009","journal-title":"Science"},{"issue":"14","key":"10.1016\/j.plipres.2023.101242_bb0220","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1093\/hmg\/ddg180","article-title":"A long-range Shh enhancer regulates expression in the developing limb and fin and is associated with preaxial polydactyly","volume":"12","author":"Lettice","year":"2003","journal-title":"Hum. Mol. Genet."},{"issue":"7414","key":"10.1016\/j.plipres.2023.101242_bb0225","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1038\/nature11279","article-title":"The long-range interaction landscape of gene promoters","volume":"489","author":"Sanyal","year":"2012","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.plipres.2023.101242_bb0230","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1101\/gr.275901.121","article-title":"Long-range promoter-enhancer contacts are conserved during evolution and contribute to gene expression robustness","volume":"32","author":"Laverre","year":"2022","journal-title":"Genome Res."},{"issue":"3","key":"10.1016\/j.plipres.2023.101242_bb0235","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1016\/S0021-9258(19)41903-0","article-title":"Enzyme deletions and essential fatty acid metabolism in cultured cells","volume":"250","author":"Mathers","year":"1975","journal-title":"J. Biol. Chem."},{"issue":"5","key":"10.1016\/j.plipres.2023.101242_bb0240","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/0306-9877(80)90099-7","article-title":"The reversibility of cancer: the relevance of cyclic AMP, calcium, essential fatty acids and prostaglandin E1","volume":"6","author":"Horrobin","year":"1980","journal-title":"Med. Hypotheses"},{"key":"10.1016\/j.plipres.2023.101242_bb0245","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1111\/j.1749-6632.1994.tb44366.x","article-title":"Diversity in the ability of cultured cells to elongate and desaturate essential (n-6 and n-3) fatty acids","volume":"745","author":"Grammatikos","year":"1994","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"11","key":"10.1016\/j.plipres.2023.101242_bb0250","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0028186","article-title":"FADS2 function loss at the cancer hotspot 11q13 locus diverts lipid signaling precursor synthesis to unusual eicosanoid fatty acids","volume":"6","author":"Park","year":"2011","journal-title":"PLoS One"},{"issue":"12","key":"10.1016\/j.plipres.2023.101242_bb0255","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0115610","article-title":"Loss of FADS2 function severely impairs the use of HeLa cells as an in vitro model for host response studies involving fatty acid effects","volume":"9","author":"Jaudszus","year":"2014","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.plipres.2023.101242_bb0260","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1097\/MCO.0000000000000810","article-title":"New understandings of the pathway of long-chain polyunsaturated fatty acid biosynthesis","volume":"25","author":"Brenna","year":"2022","journal-title":"Curr. Opin. Clin. Nutr. Metab. Care"},{"key":"10.1016\/j.plipres.2023.101242_bb0265","doi-asserted-by":"crossref","DOI":"10.1016\/j.plefa.2020.102183","article-title":"Polyunsaturated fatty acid biosynthesis pathway and genetics. implications for interindividual variability in prothrombotic, inflammatory conditions such as COVID-19(,, bigstar, bigstar bigstar)","volume":"162","author":"Kothapalli","year":"2020","journal-title":"Prostaglandins Leukot. Essent. Fat. Acids"},{"issue":"7","key":"10.1016\/j.plipres.2023.101242_bb0270","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.tem.2012.05.001","article-title":"PPARs at the crossroads of lipid signaling and inflammation","volume":"23","author":"Wahli","year":"2012","journal-title":"Trends Endocrinol. Metab."},{"issue":"1","key":"10.1016\/j.plipres.2023.101242_bb0275","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1097\/00041433-200402000-00004","article-title":"The multi-dimensional regulation of gene expression by fatty acids: polyunsaturated fats as nutrient sensors","volume":"15","author":"Clarke","year":"2004","journal-title":"Curr. Opin. Lipidol."},{"issue":"8","key":"10.1016\/j.plipres.2023.101242_bb0280","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1038\/nri3859","article-title":"Eicosanoid storm in infection and inflammation","volume":"15","author":"Dennis","year":"2015","journal-title":"Nat. Rev. Immunol."},{"issue":"1","key":"10.1016\/j.plipres.2023.101242_bb0285","doi-asserted-by":"crossref","first-page":"16","DOI":"10.5455\/aim.2016.24.16-19","article-title":"Maximum Time of the Effect of Antileukotriene - Zileuton in Treatment of Patients with Bronchial Asthma","volume":"24","author":"Morina","year":"2016","journal-title":"Acta Inform. Med."},{"issue":"9","key":"10.1016\/j.plipres.2023.101242_bb0290","doi-asserted-by":"crossref","first-page":"3911","DOI":"10.1096\/fj.15-271783","article-title":"The fatty acid desaturase 2 (FADS2) gene product catalyzes Delta4 desaturation to yield n-3 docosahexaenoic acid and n-6 docosapentaenoic acid in human cells","volume":"29","author":"Park","year":"2015","journal-title":"FASEB J."},{"issue":"2","key":"10.1016\/j.plipres.2023.101242_bb0295","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.bbalip.2015.11.007","article-title":"Palmitic acid (16:0) competes with omega-6 linoleic and omega-3 a-linolenic acids for FADS2 mediated Delta6-desaturation","volume":"1861","author":"Park","year":"2016","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.plipres.2023.101242_bb0300","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.plefa.2017.11.004","article-title":"The role of fatty acid desaturase (FADS) genes in oleic acid metabolism: FADS1 Delta7 desaturates 11-20:1 to 7,11-20:2","volume":"128","author":"Park","year":"2018","journal-title":"Prostaglandins Leukot. Essent. Fat. Acids"},{"issue":"2","key":"10.1016\/j.plipres.2023.101242_bb0305","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1097\/MCO.0000000000000254","article-title":"Desaturase and elongase-limiting endogenous long-chain polyunsaturated fatty acid biosynthesis","volume":"19","author":"Zhang","year":"2016","journal-title":"Curr. Opin. Clin. Nutr. Metab. Care"},{"issue":"6","key":"10.1016\/j.plipres.2023.101242_bb0310","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.108738","article-title":"Apocryphal FADS2 activity promotes fatty acid diversification in cancer","volume":"34","author":"Young","year":"2021","journal-title":"Cell Rep."},{"issue":"3","key":"10.1016\/j.plipres.2023.101242_bb0315","article-title":"Fatty acid desaturase 2 (FADS2) but not FADS1 desaturates branched chain and odd chain saturated fatty acids","volume":"1865","author":"Wang","year":"2020","journal-title":"Biochim. Biophys. Acta Mol. Cell Biol. Lipids"},{"issue":"2","key":"10.1016\/j.plipres.2023.101242_bb0320","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1006\/geno.2000.6196","article-title":"cDNA cloning, genomic structure, and chromosomal localization of three members of the human fatty acid desaturase family","volume":"66","author":"Marquardt","year":"2000","journal-title":"Genomics"},{"issue":"2","key":"10.1016\/j.plipres.2023.101242_bb0325","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.bbrc.2018.09.132","article-title":"Conversion of dietary trans-vaccenic acid to trans11,cis13-conjugated linoleic acid in the rat lactating mammary gland by Fatty Acid Desaturase 3-catalyzed methyl-end Delta13-desaturation","volume":"505","author":"Garcia","year":"2018","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"7","key":"10.1016\/j.plipres.2023.101242_bb0330","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1074\/jbc.AC119.011883","article-title":"FADS3 is a Delta14Z sphingoid base desaturase that contributes to gender differences in the human plasma sphingolipidome","volume":"295","author":"Karsai","year":"2020","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.plipres.2023.101242_bb0335","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1093\/pcmedi\/pbz017","article-title":"The expanded role of fatty acid metabolism in cancer: new aspects and targets","volume":"2","author":"Chen","year":"2019","journal-title":"Prec. Clin. Med."},{"issue":"11","key":"10.1016\/j.plipres.2023.101242_bb0340","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1038\/nrc.2016.89","article-title":"The multifaceted roles of fatty acid synthesis in cancer","volume":"16","author":"Rohrig","year":"2016","journal-title":"Nat. Rev. Cancer"},{"issue":"4","key":"10.1016\/j.plipres.2023.101242_bb0345","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.plipres.2013.08.005","article-title":"Lipogenesis and lipolysis: the pathways exploited by the cancer cells to acquire fatty acids","volume":"52","author":"Zaidi","year":"2013","journal-title":"Prog. Lipid Res."},{"issue":"3","key":"10.1016\/j.plipres.2023.101242_bb0350","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/nrc2809","article-title":"Eicosanoids and cancer","volume":"10","author":"Wang","year":"2010","journal-title":"Nat. Rev. Cancer"},{"issue":"1-4","key":"10.1016\/j.plipres.2023.101242_bb0355","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.prostaglandins.2011.08.004","article-title":"Regulation of inflammation in cancer by eicosanoids","volume":"96","author":"Greene","year":"2011","journal-title":"Prostaglandins Other Lipid Mediat."},{"issue":"5","key":"10.1016\/j.plipres.2023.101242_bb0360","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1042\/BST20160474","article-title":"Omega-3 fatty acids and inflammatory processes: from molecules to man","volume":"45","author":"Calder","year":"2017","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.plipres.2023.101242_bb0365","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1146\/annurev.nutr.24.121803.063211","article-title":"Structure, function, and dietary regulation of delta6, delta5, and delta9 desaturases","volume":"24","author":"Nakamura","year":"2004","journal-title":"Annu. Rev. Nutr."},{"issue":"1","key":"10.1016\/j.plipres.2023.101242_bb0370","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.plefa.2012.04.011","article-title":"Insertion-deletions in a FADS2 intron 1 conserved regulatory locus control expression of fatty acid desaturases 1 and 2 and modulate response to simvastatin","volume":"87","author":"Reardon","year":"2012","journal-title":"Prostaglandins Leukot. Essent. Fat. Acids"},{"issue":"7","key":"10.1016\/j.plipres.2023.101242_bb0375","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1093\/molbev\/msw049","article-title":"Positive Selection on a Regulatory Insertion-Deletion Polymorphism in FADS2 Influences Apparent Endogenous Synthesis of Arachidonic Acid","volume":"33","author":"Kothapalli","year":"2016","journal-title":"Mol. Biol. Evol."},{"issue":"6","key":"10.1016\/j.plipres.2023.101242_bb0380","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1093\/ajcn\/nqy063","article-title":"A regulatory insertion-deletion polymorphism in the FADS gene cluster influences PUFA and lipid profiles among Chinese adults: a population-based study","volume":"107","author":"Li","year":"2018","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.plipres.2023.101242_bb0385","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.942798","article-title":"Fatty acid desaturase 1 (FADS1) is a cancer marker for patient survival and a potential novel target for precision cancer treatment","volume":"12","author":"Heravi","year":"2022","journal-title":"Front. Oncol."},{"issue":"1","key":"10.1016\/j.plipres.2023.101242_bb0390","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1002\/(SICI)1096-9896(199901)187:1<28::AID-PATH166>3.0.CO;2-R","article-title":"Chromosomes, 11Q and cancer: a review","volume":"187","author":"Koreth","year":"1999","journal-title":"J. Pathol."},{"issue":"4","key":"10.1016\/j.plipres.2023.101242_bb0395","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/S0092-8674(02)00864-4","article-title":"HIV-1 integration in the human genome favors active genes and local hotspots","volume":"110","author":"Schroder","year":"2002","journal-title":"Cell"},{"issue":"1-2","key":"10.1016\/j.plipres.2023.101242_bb0400","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1159\/000109612","article-title":"The molecular basis of the folate-sensitive fragile site FRA11A at 11q13","volume":"119","author":"Debacker","year":"2007","journal-title":"Cytogenet. Genome Res."},{"issue":"4","key":"10.1016\/j.plipres.2023.101242_bb0405","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.ygeno.2014.01.001","article-title":"One in four individuals of African-American ancestry harbors a 5.5kb deletion at chromosome 11q13.1","volume":"103","author":"Zainabadi","year":"2014","journal-title":"Genomics"},{"issue":"1","key":"10.1016\/j.plipres.2023.101242_bb0410","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/0165-4608(88)90006-4","article-title":"Translocation breakpoint in t(11;14) in B-cell leukemia is not at the rare fragile site at 11q13.3","volume":"31","author":"Puspurs","year":"1988","journal-title":"Cancer Genet. Cytogenet."},{"issue":"6","key":"10.1016\/j.plipres.2023.101242_bb0415","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/j.ygeno.2005.02.014","article-title":"A 700-kb physical and transcription map of the cervical cancer tumor suppressor gene locus on chromosome 11q13","volume":"85","author":"Zainabadi","year":"2005","journal-title":"Genomics"},{"issue":"5","key":"10.1016\/j.plipres.2023.101242_bb0420","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.tig.2008.03.001","article-title":"The functional impact of structural variation in humans","volume":"24","author":"Hurles","year":"2008","journal-title":"Trends Genet."},{"issue":"1","key":"10.1016\/j.plipres.2023.101242_bb0425","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1002\/cjp2.118","article-title":"Breast cancer metastasis to gynaecological organs: a clinico-pathological and molecular profiling study","volume":"5","author":"Kutasovic","year":"2019","journal-title":"J. Pathol. Clin. Res."},{"issue":"3","key":"10.1016\/j.plipres.2023.101242_bb0430","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.jmoldx.2011.01.011","article-title":"Copy number gains in 11q13 and 8q24 [corrected] are highly linked to prognosis in cutaneous malignant melanoma","volume":"13","author":"Gerami","year":"2011","journal-title":"J. Mol. Diagn."},{"issue":"13","key":"10.1016\/j.plipres.2023.101242_bb0435","doi-asserted-by":"crossref","first-page":"2203","DOI":"10.1016\/S0959-8049(97)00198-6","article-title":"Amplification of 11q13 DNA markers in head and neck squamous cell carcinomas: correlation with clinical outcome","volume":"33","author":"Muller","year":"1997","journal-title":"Eur. J. Cancer"},{"issue":"11","key":"10.1016\/j.plipres.2023.101242_bb0440","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1001\/archotol.1993.01880230084013","article-title":"Chromosome 11Q13 amplification in head and neck squamous cell carcinoma","volume":"119","author":"Williams","year":"1993","journal-title":"Arch. Otolaryngol. Head Neck Surg."},{"issue":"2","key":"10.1016\/j.plipres.2023.101242_bb0445","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1159\/000095228","article-title":"Molecular cytogenetic characterization of the 11q13 amplicon in head and neck squamous cell carcinoma","volume":"115","author":"Jin","year":"2006","journal-title":"Cytogenet. Genome Res."},{"issue":"4","key":"10.1016\/j.plipres.2023.101242_bb0450","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1002\/ijc.2910580420","article-title":"The PRAD-1\/cyclin D1 oncogene product accumulates aberrantly in a subset of colorectal carcinomas","volume":"58","author":"Bartkova","year":"1994","journal-title":"Int. J. Cancer"},{"issue":"11","key":"10.1016\/j.plipres.2023.101242_bb0455","first-page":"2238","article-title":"Allelic deletions on chromosome 11q13 in multiple endocrine neoplasia type 1-associated and sporadic gastrinomas and pancreatic endocrine tumors","volume":"57","author":"Debelenko","year":"1997","journal-title":"Cancer Res."},{"issue":"6","key":"10.1016\/j.plipres.2023.101242_bb0460","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1158\/1055-9965.EPI-08-0983","article-title":"Two independent prostate cancer risk-associated Loci at 11q13","volume":"18","author":"Zheng","year":"2009","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"issue":"4","key":"10.1016\/j.plipres.2023.101242_bb0465","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1182\/blood.V93.4.1330","article-title":"Molecular analysis of 11q13 breakpoints in multiple myeloma","volume":"93","author":"Ronchetti","year":"1999","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.plipres.2023.101242_bb0470","doi-asserted-by":"crossref","first-page":"620","DOI":"10.21037\/tcr.2017.05.19","article-title":"Renal cell carcinoma: the search for a reliable biomarker","volume":"6","author":"Farber","year":"2017","journal-title":"Transl. Cancer Res."},{"issue":"1","key":"10.1016\/j.plipres.2023.101242_bb0475","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1186\/s12943-017-0686-8","article-title":"11q deletion in neuroblastoma: a review of biological and clinical implications","volume":"16","author":"Mlakar","year":"2017","journal-title":"Mol. Cancer"},{"issue":"1","key":"10.1016\/j.plipres.2023.101242_bb0480","doi-asserted-by":"crossref","first-page":"13806","DOI":"10.1038\/s41598-019-50327-5","article-title":"Clinical Features of Neuroblastoma With 11q Deletion: An Increase in Relapse Probabilities In Localized And 4S Stages","volume":"9","author":"Juan Ribelles","year":"2019","journal-title":"Sci. Rep."},{"issue":"22","key":"10.1016\/j.plipres.2023.101242_bb0485","doi-asserted-by":"crossref","first-page":"6875","DOI":"10.1158\/1078-0432.CCR-17-0593","article-title":"Deletion of 11q in Neuroblastomas Drives Sensitivity to PARP Inhibition","volume":"23","author":"Sanmartin","year":"2017","journal-title":"Clin. Cancer Res."},{"issue":"17","key":"10.1016\/j.plipres.2023.101242_bb0490","doi-asserted-by":"crossref","first-page":"5785","DOI":"10.1158\/1078-0432.CCR-03-0410","article-title":"Amplification of the BRCA2 pathway gene EMSY in sporadic breast cancer is related to negative outcome","volume":"10","author":"Rodriguez","year":"2004","journal-title":"Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.plipres.2023.101242_bb0495","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1002\/gcc.2870090108","article-title":"Patterns of DNA amplification at band q13 of chromosome 11 in human breast cancer","volume":"9","author":"Karlseder","year":"1994","journal-title":"Genes Chromosom. Cancer"},{"issue":"4","key":"10.1016\/j.plipres.2023.101242_bb0500","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1001\/jamaoncol.2016.5688","article-title":"Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-years for 32 Cancer Groups, 1990 to 2015: A Systematic Analysis for the Global Burden of Disease Study","volume":"3","author":"C. Global Burden of Disease Cancer","year":"2017","journal-title":"JAMA Oncol."},{"issue":"1","key":"10.1016\/j.plipres.2023.101242_bb0505","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3322\/caac.21387","article-title":"Cancer Statistics, 2017","volume":"67","author":"Siegel","year":"2017","journal-title":"CA Cancer J. Clin."},{"issue":"6","key":"10.1016\/j.plipres.2023.101242_bb0510","doi-asserted-by":"crossref","first-page":"394","DOI":"10.3322\/caac.21492","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray","year":"2018","journal-title":"CA Cancer J. Clin."},{"issue":"3","key":"10.1016\/j.plipres.2023.101242_bb0515","first-page":"285","article-title":"Amplification of the int-2 gene in primary human breast tumors","volume":"2","author":"Lidereau","year":"1988","journal-title":"Oncogene. Res."},{"issue":"8","key":"10.1016\/j.plipres.2023.101242_bb0520","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1093\/clinchem\/48.8.1362","article-title":"Mammaglobin a: a promising marker for breast cancer","volume":"48","author":"O\u2019Brien","year":"2002","journal-title":"Clin. Chem."},{"issue":"1","key":"10.1016\/j.plipres.2023.101242_bb0525","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s10549-009-0317-1","article-title":"A 7 Mb region within 11q13 may contain a high penetrance gene for breast cancer","volume":"118","author":"Rosa-Rosa","year":"2009","journal-title":"Breast Cancer Res. Treat."},{"issue":"5","key":"10.1016\/j.plipres.2023.101242_bb0530","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1038\/onc.2009.364","article-title":"Focal amplification and oncogene dependency of GAB2 in breast cancer","volume":"29","author":"Bocanegra","year":"2010","journal-title":"Oncogene"},{"issue":"6","key":"10.1016\/j.plipres.2023.101242_bb0535","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1038\/ng.586","article-title":"Genome-wide association study identifies five new breast cancer susceptibility loci","volume":"42","author":"Turnbull","year":"2010","journal-title":"Nat. Genet."},{"issue":"7","key":"10.1016\/j.plipres.2023.101242_bb0540","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1002\/humu.22089","article-title":"11q13 is a susceptibility locus for hormone receptor positive breast cancer","volume":"33","author":"Lambrechts","year":"2012","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.plipres.2023.101242_bb0545","doi-asserted-by":"crossref","DOI":"10.1093\/annonc\/mdz239.012","article-title":"Pan-cancer genomic landscape of the cyclin D1\/FGF3,4,19 (11q13) amplicon including associations with HPV status, and ESR1 and AR alterations","volume":"30","author":"Schrock","year":"2019","journal-title":"Ann. Oncol."},{"issue":"9","key":"10.1016\/j.plipres.2023.101242_bb0550","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1158\/2159-8290.CD-15-1227","article-title":"Genome-wide meta-analyses of breast, ovarian, and prostate cancer association studies identify multiple new susceptibility loci shared by at least two cancer types","volume":"6","author":"Kar","year":"2016","journal-title":"Cancer Discov."},{"key":"10.1016\/j.plipres.2023.101242_bb0555","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.breast.2020.07.010","article-title":"Clinicopathological and genomic features of breast mucinous carcinoma","volume":"53","author":"Lu","year":"2020","journal-title":"Breast"},{"issue":"5","key":"10.1016\/j.plipres.2023.101242_bb0560","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1093\/carcin\/bgt404","article-title":"Genome-wide association study identifies 25 known breast cancer susceptibility loci as risk factors for triple-negative breast cancer","volume":"35","author":"Purrington","year":"2014","journal-title":"Carcinogenesis"},{"issue":"3","key":"10.1016\/j.plipres.2023.101242_bb0565","first-page":"467","article-title":"Identical allelic loss on chromosome 11q13 in microdissected in situ and invasive human breast cancer","volume":"55","author":"Zhuang","year":"1995","journal-title":"Cancer Res."},{"issue":"40","key":"10.1016\/j.plipres.2023.101242_bb0570","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.15585\/mmwr.mm6540a1","article-title":"Patterns and Trends in Age-Specific Black-White Differences in Breast Cancer Incidence and Mortality - United States, 1999-2014","volume":"65","author":"Richardson","year":"2016","journal-title":"MMWR Morb. Mortal. Wkly Rep."},{"issue":"14","key":"10.1016\/j.plipres.2023.101242_bb0575","doi-asserted-by":"crossref","first-page":"2138","DOI":"10.1002\/cncr.29935","article-title":"Understanding and effectively addressing breast cancer in African American women: Unpacking the social context","volume":"122","author":"Williams","year":"2016","journal-title":"Cancer"},{"key":"10.1016\/j.plipres.2023.101242_bb0580","doi-asserted-by":"crossref","first-page":"170","DOI":"10.3389\/fgene.2016.00170","article-title":"Admixture Mapping of African-American Women in the AMBER Consortium Identifies New Loci for Breast Cancer and Estrogen-Receptor Subtypes","volume":"7","author":"Ruiz-Narvaez","year":"2016","journal-title":"Front. Genet."},{"issue":"4","key":"10.1016\/j.plipres.2023.101242_bb0585","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.3892\/ol.2015.3608","article-title":"Comparative genomic hybridization analysis of invasive ductal breast carcinomas in the Chinese population","volume":"10","author":"Zhang","year":"2015","journal-title":"Oncol. Lett."},{"issue":"11","key":"10.1016\/j.plipres.2023.101242_bb0590","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0188068","article-title":"Prognostic significance of cyclin D1 protein expression and gene amplification in invasive breast carcinoma","volume":"12","author":"Ortiz","year":"2017","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.plipres.2023.101242_bb0595","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/0277-5379(90)90009-I","article-title":"Gene amplification on chromosome band 11q13 and oestrogen receptor status in breast cancer","volume":"26","author":"Fantl","year":"1990","journal-title":"Eur. J. Cancer"},{"issue":"8","key":"10.1016\/j.plipres.2023.101242_bb0600","first-page":"2069","article-title":"Overexpression of cyclin D1 messenger RNA predicts for poor prognosis in estrogen receptor-positive breast cancer","volume":"5","author":"Kenny","year":"1999","journal-title":"Clin. Cancer Res."},{"issue":"2","key":"10.1016\/j.plipres.2023.101242_bb0605","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1002\/ijc.25034","article-title":"High CCND1 amplification identifies a group of poor prognosis women with estrogen receptor positive breast cancer","volume":"127","author":"Roy","year":"2010","journal-title":"Int. J. Cancer"},{"issue":"5","key":"10.1016\/j.plipres.2023.101242_bb0610","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1111\/cas.13982","article-title":"Integrative molecular profiling identifies a novel cluster of estrogen receptor-positive breast cancer in very young women","volume":"110","author":"Park","year":"2019","journal-title":"Cancer Sci."},{"key":"10.1016\/j.plipres.2023.101242_bb0615","article-title":"A Rare Eicosanoid Precursor Analogue, Sciadonic Acid (5Z,11Z,14Z-20:3), Detected In Vivo in Hormone Positive Breast Cancer Tissue","author":"Park","year":"2018","journal-title":"PLEFA"},{"issue":"2","key":"10.1016\/j.plipres.2023.101242_bb0620","first-page":"253","article-title":"Expression of human delta-6-desaturase is associated with aggressiveness of human breast cancer","volume":"12","author":"Lane","year":"2003","journal-title":"Int. J. Mol. Med."},{"issue":"3","key":"10.1016\/j.plipres.2023.101242_bb0625","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/0005-2760(91)90142-5","article-title":"Extensive incorporation of dietary delta-5,11,14 eicosatrienoate into the phosphatidylinositol pool","volume":"1085","author":"Berger","year":"1991","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.plipres.2023.101242_bb0630","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1476-511X-1-5","article-title":"Epidermal anti-Inflammatory properties of 5,11,14 20:3: effects on mouse ear edema, PGE2 levels in cultured keratinocytes, and PPAR activation","volume":"1","author":"Berger","year":"2002","journal-title":"Lipids Health Dis."},{"issue":"18","key":"10.1016\/j.plipres.2023.101242_bb0635","doi-asserted-by":"crossref","first-page":"4928","DOI":"10.1046\/j.0014-2956.2001.02423.x","article-title":"Metabolic characterization of sciadonic acid (5c,11c,14c-eicosatrienoic acid) as an effective substitute for arachidonate of phosphatidylinositol","volume":"268","author":"Tanaka","year":"2001","journal-title":"Eur. J. Biochem."},{"issue":"3","key":"10.1016\/j.plipres.2023.101242_bb0640","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/s11745-001-0724-6","article-title":"A new delta 7-polyunsaturated fatty acid in Taxus spp. Seed lipids, dihomotaxoleic (7,11-20:2) acid","volume":"36","author":"Destaillats","year":"2001","journal-title":"Lipids"},{"issue":"12","key":"10.1016\/j.plipres.2023.101242_bb0645","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1007\/BF02534595","article-title":"Distribution of methylene and nonmethylene-interrupted dienoic fatty acids in polar lipids and triacylglycerols of selected tissues of the hardshell clam (Mercenaria mercenaria)","volume":"17","author":"Klingensmith","year":"1982","journal-title":"Lipids"},{"issue":"6","key":"10.1016\/j.plipres.2023.101242_bb0650","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.biochi.2009.03.020","article-title":"Non-methylene-interrupted fatty acids from marine invertebrates: Occurrence, characterization and biological properties","volume":"91","author":"Barnathan","year":"2009","journal-title":"Biochimie"},{"issue":"4","key":"10.1016\/j.plipres.2023.101242_bb0655","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1007\/s10555-010-9264-x","article-title":"Cytochrome P450-derived eicosanoids: the neglected pathway in cancer","volume":"29","author":"Panigrahy","year":"2010","journal-title":"Cancer Metastasis Rev."},{"key":"10.1016\/j.plipres.2023.101242_bb0660","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1146\/annurev.pharmtox.38.1.97","article-title":"Cyclooxygenases 1 and 2","volume":"38","author":"Vane","year":"1998","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"issue":"4","key":"10.1016\/j.plipres.2023.101242_bb0665","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/0090-6980(85)90078-4","article-title":"Double bond requirement for the 5-lipoxygenase pathway","volume":"29","author":"Wei","year":"1985","journal-title":"Prostaglandins"},{"issue":"Suppl_10","key":"10.1016\/j.plipres.2023.101242_bb0670","doi-asserted-by":"crossref","first-page":"x3","DOI":"10.1093\/annonc\/mdz281","article-title":"Overview of the relevance of PI3K pathway in HR-positive breast cancer","volume":"30","author":"Vasan","year":"2019","journal-title":"Ann. Oncol."},{"issue":"5","key":"10.1016\/j.plipres.2023.101242_bb0675","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1038\/nrc2842","article-title":"Phosphoinositide signalling in cancer: beyond PI3K and PTEN","volume":"10","author":"Bunney","year":"2010","journal-title":"Nat. Rev. Cancer"},{"issue":"33","key":"10.1016\/j.plipres.2023.101242_bb0680","doi-asserted-by":"crossref","first-page":"4452","DOI":"10.1200\/JCO.2010.34.4879","article-title":"Phosphatidylinositol 3-kinase and antiestrogen resistance in breast cancer","volume":"29","author":"Miller","year":"2011","journal-title":"J. Clin. Oncol."},{"issue":"2","key":"10.1016\/j.plipres.2023.101242_bb0685","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/0003-9861(89)90474-8","article-title":"Substrate specificity of the agonist-stimulated release of polyunsaturated fatty acids from vascular endothelial cells","volume":"274","author":"Rosenthal","year":"1989","journal-title":"Arch. Biochem. Biophys."},{"issue":"10","key":"10.1016\/j.plipres.2023.101242_bb0690","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1016\/S1470-2045(13)70301-2","article-title":"Sex hormones and risk of breast cancer in premenopausal women: a collaborative reanalysis of individual participant data from seven prospective studies","volume":"14","author":"Endogenous","year":"2013","journal-title":"Lancet Oncol."},{"issue":"11","key":"10.1016\/j.plipres.2023.101242_bb0695","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1007\/BF02535651","article-title":"Effect of various steroids on the biosynthesis of arachidonic acid in isolated hepatocytes and HTC cells","volume":"23","author":"Marra","year":"1988","journal-title":"Lipids"},{"key":"10.1016\/j.plipres.2023.101242_bb0700","doi-asserted-by":"crossref","DOI":"10.1016\/j.plefa.2021.102312","article-title":"The aromatase inhibitor letrozole restores FADS2 function in ER+ MCF7 human breast cancer cells","volume":"171","author":"Park","year":"2021","journal-title":"Prostaglandins Leukot. Essent. Fat. Acids"},{"issue":"5","key":"10.1016\/j.plipres.2023.101242_bb0705","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1002\/(SICI)1097-0215(20000301)85:5<643::AID-IJC8>3.0.CO;2-Z","article-title":"Gamma linolenic acid with tamoxifen as primary therapy in breast cancer","volume":"85","author":"Kenny","year":"2000","journal-title":"Int. J. Cancer"},{"issue":"6","key":"10.1016\/j.plipres.2023.101242_bb0710","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1002\/ijc.20096","volume":"109","author":"Menendez","year":"2004","journal-title":"Int. J. Cancer"},{"issue":"3","key":"10.1016\/j.plipres.2023.101242_bb0715","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/S0959-8049(00)00408-1","article-title":"Effects of gamma-linolenic acid and oleic acid on paclitaxel cytotoxicity in human breast cancer cells","volume":"37","author":"Menendez","year":"2001","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.plipres.2023.101242_bb0720","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.breast.2019.04.001","article-title":"Low eicosapentaenoic acid and gamma-linolenic acid levels in breast adipose tissue are associated with inflammatory breast cancer","volume":"45","author":"Chas","year":"2019","journal-title":"Breast"},{"issue":"4","key":"10.1016\/j.plipres.2023.101242_bb0725","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/0952-3278(89)90036-7","article-title":"Premenstrual syndrome and premenstrual breast pain (cyclical mastalgia): disorders of essential fatty acid (EFA) metabolism","volume":"37","author":"Horrobin","year":"1989","journal-title":"Prostaglandins Leukot. Essent. Fat. Acids"},{"issue":"5","key":"10.1016\/j.plipres.2023.101242_bb0730","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1210\/me.2009-0293","article-title":"Cytosolic phospholipase A2 activation correlates with HER2 overexpression and mediates estrogen-dependent breast cancer cell growth","volume":"24","author":"Caiazza","year":"2010","journal-title":"Mol. Endocrinol."},{"issue":"1","key":"10.1016\/j.plipres.2023.101242_bb0735","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.jnutbio.2012.06.005","article-title":"High levels of arachidonic acid and peroxisome proliferator-activated receptor-alpha in breast cancer tissues are associated with promoting cancer cell proliferation","volume":"24","author":"Chang","year":"2013","journal-title":"J. Nutr. Biochem."},{"issue":"5","key":"10.1016\/j.plipres.2023.101242_bb0740","doi-asserted-by":"crossref","first-page":"3332","DOI":"10.1016\/j.clnu.2020.11.004","article-title":"Genetically predicted plasma phospholipid arachidonic acid concentrations and 10 site-specific cancers in UK biobank and genetic consortia participants: A mendelian randomization study","volume":"40","author":"Larsson","year":"2021","journal-title":"Clin. Nutr."},{"issue":"10","key":"10.1016\/j.plipres.2023.101242_bb0745","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.molmed.2008.08.005","article-title":"Arachidonic-acid-derived eicosanoids: roles in biology and immunopathology","volume":"14","author":"Harizi","year":"2008","journal-title":"Trends Mol. Med."},{"issue":"4","key":"10.1016\/j.plipres.2023.101242_bb0750","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1186\/bcr1678","article-title":"Inflammation and breast cancer. Cyclooxygenase\/prostaglandin signaling and breast cancer","volume":"9","author":"Howe","year":"2007","journal-title":"Breast Cancer Res."},{"issue":"11","key":"10.1016\/j.plipres.2023.101242_bb0755","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0015540","article-title":"Functional interaction between acyl-CoA synthetase 4, lipooxygenases and cyclooxygenase-2 in the aggressive phenotype of breast cancer cells","volume":"5","author":"Maloberti","year":"2010","journal-title":"PLoS One"},{"issue":"1-2","key":"10.1016\/j.plipres.2023.101242_bb0760","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.canlet.2014.03.010","article-title":"Prostaglandin E3 metabolism and cancer","volume":"348","author":"Yang","year":"2014","journal-title":"Cancer Lett."},{"issue":"27","key":"10.1016\/j.plipres.2023.101242_bb0765","doi-asserted-by":"crossref","first-page":"16709","DOI":"10.1074\/jbc.272.27.16709","article-title":"Properties and regulation of cytosolic phospholipase A2","volume":"272","author":"Leslie","year":"1997","journal-title":"J. Biol. Chem."},{"issue":"26","key":"10.1016\/j.plipres.2023.101242_bb0770","doi-asserted-by":"crossref","first-page":"8070","DOI":"10.1073\/pnas.1424355112","article-title":"COX\/mPGES-1\/PGE2 pathway depicts an inflammatory-dependent high-risk neuroblastoma subset","volume":"112","author":"Larsson","year":"2015","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"4","key":"10.1016\/j.plipres.2023.101242_bb0775","first-page":"325","article-title":"Review: molecular pathology of cyclooxygenase-2 in cancer-induced angiogenesis","volume":"31","author":"Fosslien","year":"2001","journal-title":"Ann. Clin. Lab. Sci."},{"issue":"9\u201310","key":"10.1016\/j.plipres.2023.101242_bb0780","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.cca.2010.12.026","article-title":"Cyclooxygenase-2 in oncogenesis","volume":"412","author":"Rizzo","year":"2011","journal-title":"Clin. Chim. Acta"},{"issue":"5","key":"10.1016\/j.plipres.2023.101242_bb0785","doi-asserted-by":"crossref","first-page":"5683","DOI":"10.1002\/jcp.27411","article-title":"Cyclooxygenase-2 in cancer: A review","volume":"234","author":"Hashemi Goradel","year":"2019","journal-title":"J. Cell. Physiol."},{"issue":"5","key":"10.1016\/j.plipres.2023.101242_bb0790","doi-asserted-by":"crossref","first-page":"H1528","DOI":"10.1152\/ajpheart.00406.2002","article-title":"CYP4A metabolites of arachidonic acid and VEGF are mediators of skeletal muscle angiogenesis","volume":"284","author":"Amaral","year":"2003","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"2","key":"10.1016\/j.plipres.2023.101242_bb0795","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1038\/sj.bjc.6606025","article-title":"Cytosolic phospholipase A2-alpha expression in breast cancer is associated with EGFR expression and correlates with an adverse prognosis in luminal tumours","volume":"104","author":"Caiazza","year":"2011","journal-title":"Br. J. Cancer"},{"issue":"2","key":"10.1016\/j.plipres.2023.101242_bb0800","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.soncn.2019.02.001","article-title":"Ovarian Cancer: An Integrated Review","volume":"35","author":"Stewart","year":"2019","journal-title":"Semin. Oncol. Nurs."},{"issue":"1","key":"10.1016\/j.plipres.2023.101242_bb0805","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.ajpath.2020.09.006","article-title":"The Origin of Ovarian Cancer Species and Precancerous Landscape","volume":"191","author":"Shih","year":"2021","journal-title":"Am. J. Pathol."},{"issue":"4","key":"10.1016\/j.plipres.2023.101242_bb0810","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1080\/21541248.2016.1213089","article-title":"The Group I Pak inhibitor Frax-1036 sensitizes 11q13-amplified ovarian cancer cells to the cytotoxic effects of Rottlerin","volume":"8","author":"Prudnikova","year":"2017","journal-title":"Small GTPases"},{"issue":"1","key":"10.1016\/j.plipres.2023.101242_bb0815","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/BF02532589","article-title":"In vitro activity of the fatty acyl desaturases of human cancerous and noncancerous tissues","volume":"11","author":"Nakazawa","year":"1976","journal-title":"Lipids"},{"issue":"7744","key":"10.1016\/j.plipres.2023.101242_bb0820","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1038\/s41586-019-0904-1","article-title":"Evidence for an alternative fatty acid desaturation pathway increasing cancer plasticity","volume":"566","author":"Vriens","year":"2019","journal-title":"Nature"},{"issue":"12","key":"10.1016\/j.plipres.2023.101242_bb0825","doi-asserted-by":"crossref","first-page":"107806","DOI":"10.1016\/j.celrep.2020.107806","article-title":"mTOR Signaling and SREBP Activity Increase FADS2 Expression and Can Activate Sapienate Biosynthesis","volume":"31","author":"Triki","year":"2020","journal-title":"Cell Rep."},{"issue":"7744","key":"10.1016\/j.plipres.2023.101242_bb0830","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/d41586-019-00352-1","article-title":"Tumours use a metabolic twist to make lipids","volume":"566","author":"Snaebjornsson","year":"2019","journal-title":"Nature"},{"issue":"20","key":"10.1016\/j.plipres.2023.101242_bb0835","doi-asserted-by":"crossref","first-page":"5149","DOI":"10.1158\/0008-5472.CAN-19-2453","article-title":"Stearoyl CoA Desaturase Regulates Ferroptosis in Ovarian Cancer Offering New Therapeutic Perspectives","volume":"79","author":"Carbone","year":"2019","journal-title":"Cancer Res."},{"issue":"20","key":"10.1016\/j.plipres.2023.101242_bb0840","doi-asserted-by":"crossref","first-page":"5355","DOI":"10.1158\/0008-5472.CAN-19-0369","article-title":"Stearoyl-CoA Desaturase 1 Protects Ovarian Cancer Cells from Ferroptotic Cell Death","volume":"79","author":"Tesfay","year":"2019","journal-title":"Cancer Res."},{"issue":"9","key":"10.1016\/j.plipres.2023.101242_bb0845","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1038\/cr.2016.95","article-title":"Ferroptosis is an autophagic cell death process","volume":"26","author":"Gao","year":"2016","journal-title":"Cell Res."},{"issue":"8","key":"10.1016\/j.plipres.2023.101242_bb0855","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.2174\/1386207323666200925104911","article-title":"FADS1 is a Prognostic Biomarker in Bladder Cancer: A Study Based on TCGA Data","volume":"24","author":"Lu","year":"2020","journal-title":"Comb. Chem. High Throughput Screen."},{"issue":"1","key":"10.1016\/j.plipres.2023.101242_bb0860","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.urolonc.2020.08.016","article-title":"Urinary biomarkers in bladder cancer: A review of the current landscape and future directions","volume":"39","author":"Ng","year":"2021","journal-title":"Urol. Oncol."},{"issue":"1","key":"10.1016\/j.plipres.2023.101242_bb0865","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/nrc3817","article-title":"Molecular biology of bladder cancer: new insights into pathogenesis and clinical diversity","volume":"15","author":"Knowles","year":"2015","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.plipres.2023.101242_bb0870","doi-asserted-by":"crossref","first-page":"8325","DOI":"10.2147\/CMAR.S254316","article-title":"Identification of FADS1 Through Common Gene Expression Profiles for Predicting Survival in Patients with Bladder Cancer","volume":"12","author":"Jiao","year":"2020","journal-title":"Cancer Manag. Res."},{"key":"10.1016\/j.plipres.2023.101242_bb0875","article-title":"Construction and External Validation of a Ferroptosis-Related Gene Signature of Predictive Value for the Overall Survival in Bladder Cancer","volume":"8","author":"Liu","year":"2021","journal-title":"Front. Mol. Biosci."},{"issue":"7","key":"10.1016\/j.plipres.2023.101242_bb0880","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1080\/01635581.2018.1497668","article-title":"Decreased Oleic Acid and Marine n - 3 Polyunsaturated Fatty Acids in Tunisian Patients with Urothelial Bladder Cancer","volume":"70","author":"Ben Fradj","year":"2018","journal-title":"Nutr. Cancer"},{"issue":"8","key":"10.1016\/j.plipres.2023.101242_bb0885","doi-asserted-by":"crossref","DOI":"10.3390\/jcm9082494","article-title":"Docosahexaenoic Acid Reverted the All-trans Retinoic Acid-Induced Cellular Proliferation of T24 Bladder Cancer Cell Line","volume":"9","author":"Costantini","year":"2020","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.plipres.2023.101242_bb0890","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/368178","article-title":"Omega-3 fatty acids inhibit tumor growth in a rat model of bladder cancer","volume":"2013","author":"Parada","year":"2013","journal-title":"Biomed. Res. Int."},{"issue":"8","key":"10.1016\/j.plipres.2023.101242_bb0895","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/j.trecan.2020.04.010","article-title":"Advanced Prostate Cancer: Treatment Advances and Future Directions","volume":"6","author":"Swami","year":"2020","journal-title":"Trends Cancer"},{"issue":"3","key":"10.1016\/j.plipres.2023.101242_bb0900","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1038\/ng.91","article-title":"Multiple loci identified in a genome-wide association study of prostate cancer","volume":"40","author":"Thomas","year":"2008","journal-title":"Nat. Genet."},{"issue":"3","key":"10.1016\/j.plipres.2023.101242_bb0905","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1038\/ng.90","article-title":"Multiple newly identified loci associated with prostate cancer susceptibility","volume":"40","author":"Eeles","year":"2008","journal-title":"Nat. Genet."},{"issue":"4","key":"10.1016\/j.plipres.2023.101242_bb0910","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1038\/ng.1104","article-title":"Common variants at 11q12, 10q26 and 3p11.2 are associated with prostate cancer susceptibility in Japanese","volume":"44","author":"Akamatsu","year":"2012","journal-title":"Nat. Genet."},{"issue":"7","key":"10.1016\/j.plipres.2023.101242_bb0915","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1002\/pros.20528","article-title":"Suggestive genetic linkage to chromosome 11p11.2-q12.2 in hereditary prostate cancer families with primary kidney cancer","volume":"67","author":"Johanneson","year":"2007","journal-title":"Prostate"},{"issue":"3","key":"10.1016\/j.plipres.2023.101242_bb0920","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1002\/(SICI)1098-2264(199611)17:3<172::AID-GCC5>3.0.CO;2-1","article-title":"Detection of 11q13 amplification as the origin of a homogeneously staining region in small cell lung cancer by chromosome microdissection","volume":"17","author":"Xu","year":"1996","journal-title":"Genes Chromosom. Cancer"},{"key":"10.1016\/j.plipres.2023.101242_bb0925","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.3389\/fonc.2019.01492","article-title":"Cross-Cancer Pleiotropic Analysis Reveals Novel Susceptibility Loci for Lung Cancer","volume":"9","author":"Wang","year":"2019","journal-title":"Front. Oncol."},{"issue":"4","key":"10.1016\/j.plipres.2023.101242_bb0930","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20180570","article-title":"circFADS2 regulates lung cancer cells proliferation and invasion via acting as a sponge of miR-498","volume":"38","author":"Zhao","year":"2018","journal-title":"Biosci. Rep."},{"issue":"10","key":"10.1016\/j.plipres.2023.101242_bb0935","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.3945\/jn.110.121202","article-title":"Oral nutritional supplements containing (n-3) polyunsaturated fatty acids affect the nutritional status of patients with stage III non-small cell lung cancer during multimodality treatment","volume":"140","author":"van der Meij","year":"2010","journal-title":"J. Nutr."},{"issue":"3","key":"10.1016\/j.plipres.2023.101242_bb0940","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1001\/archdermatol.2010.4","article-title":"Prevalence of a history of skin cancer in 2007: results of an incidence-based model","volume":"146","author":"Stern","year":"2010","journal-title":"Arch. Dermatol."},{"issue":"10","key":"10.1016\/j.plipres.2023.101242_bb0945","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1002\/stem.2868","article-title":"Runx1 Role in Epithelial and Cancer Cell Proliferation Implicates Lipid Metabolism and Scd1 and Soat1 Activity","volume":"36","author":"Jain","year":"2018","journal-title":"Stem Cells"},{"issue":"2","key":"10.1016\/j.plipres.2023.101242_bb0950","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0952-3278(02)00261-2","article-title":"Role of stearoyl-coenzyme A desaturase in lipid metabolism","volume":"68","author":"Miyazaki","year":"2003","journal-title":"Prostaglandins Leukot. Essent. Fat. Acids"},{"key":"10.1016\/j.plipres.2023.101242_bb0955","series-title":"Lipids and Skin Health","article-title":"Sapienic Acid: Species-Specific Fatty Acid Metabolism of the Human Sebaceous Gland","author":"Prouty","year":"2015"},{"issue":"2","key":"10.1016\/j.plipres.2023.101242_bb0960","doi-asserted-by":"crossref","first-page":"137","DOI":"10.3177\/jnsv.50.137","article-title":"Effect of branched-chain fatty acids on fatty acid biosynthesis of human breast cancer cells","volume":"50","author":"Wongtangtintharn","year":"2004","journal-title":"J. Nutr. Sci. Vitaminol. (Tokyo)"},{"issue":"20","key":"10.1016\/j.plipres.2023.101242_bb0965","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1056\/NEJMoa050092","article-title":"Distinct sets of genetic alterations in melanoma","volume":"353","author":"Curtin","year":"2005","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.plipres.2023.101242_bb0970","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1001\/archdermatol.2009.386","article-title":"Sensitivity of fluorescence in situ hybridization for melanoma diagnosis using RREB1, MYB, Cep6, and 11q13 probes in melanoma subtypes","volume":"146","author":"Gerami","year":"2010","journal-title":"Arch. Dermatol."},{"issue":"15","key":"10.1016\/j.plipres.2023.101242_bb0975","first-page":"505","article-title":"The reversibility of cancer: evidence that malignancy in melanoma cells is gamma-linolenic acid deficiency-dependent","volume":"62","author":"Dippenaar","year":"1982","journal-title":"S. Afr. Med. J."},{"issue":"1","key":"10.1016\/j.plipres.2023.101242_bb0980","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1186\/s13045-018-0643-z","article-title":"Function and clinical significance of circRNAs in solid tumors","volume":"11","author":"Geng","year":"2018","journal-title":"J. Hematol. Oncol."},{"issue":"4","key":"10.1016\/j.plipres.2023.101242_bb0985","doi-asserted-by":"crossref","first-page":"399","DOI":"10.18632\/oncotarget.473","article-title":"Aggressiveness of human melanoma xenograft models is promoted by aneuploidy-driven gene expression deregulation","volume":"3","author":"Mathieu","year":"2012","journal-title":"Oncotarget"},{"key":"10.1016\/j.plipres.2023.101242_bb0990","author":"Lee"},{"issue":"8","key":"10.1016\/j.plipres.2023.101242_bb0995","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1111\/j.1440-1746.2005.03940.x","article-title":"Integration of hepatitis B virus DNA and hepatocellular carcinoma","volume":"20","author":"Takahashi","year":"2005","journal-title":"J. Gastroenterol. Hepatol."},{"issue":"8","key":"10.1016\/j.plipres.2023.101242_bb1000","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1111\/j.1572-0241.2005.41914.x","article-title":"Hepatitis B virus DNA integration in hepatocellular carcinoma after interferon-induced disappearance of hepatitis C virus","volume":"100","author":"Tamori","year":"2005","journal-title":"Am. J. Gastroenterol."},{"issue":"6","key":"10.1016\/j.plipres.2023.101242_bb1005","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1002\/hep.510290636","article-title":"Genetic aberrations detected by comparative genomic hybridization in hepatocellular carcinomas: their relationship to clinicopathological features","volume":"29","author":"Kusano","year":"1999","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.plipres.2023.101242_bb1010","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/0009-8981(74)90345-3","article-title":"Eicosatrienoic acid omega9 in serum lipids of patients with hepatocellular carcinoma","volume":"53","author":"Okazaki","year":"1974","journal-title":"Clin. Chim. Acta"},{"issue":"1","key":"10.1016\/j.plipres.2023.101242_bb1015","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1079\/BJN19810012","article-title":"Essential fatty acid deficiency and evidence for arachidonate synthesis in the cat","volume":"46","author":"Sinclair","year":"1981","journal-title":"Br. J. Nutr."},{"issue":"3","key":"10.1016\/j.plipres.2023.101242_bb1020","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1006\/bbrc.1999.1559","article-title":"Non-methylene-interrupted polyunsaturated fatty acids: effective substitute for arachidonate of phosphatidylinositol","volume":"264","author":"Tanaka","year":"1999","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"5","key":"10.1016\/j.plipres.2023.101242_bb1025","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1038\/modpathol.3800998","article-title":"Gene expression profiling in hepatocellular carcinoma: upregulation of genes in amplified chromosome regions","volume":"21","author":"Skawran","year":"2008","journal-title":"Mod. Pathol."},{"issue":"1","key":"10.1016\/j.plipres.2023.101242_bb1030","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1056\/NEJMra1715715","article-title":"Head and Neck Cancer","volume":"382","author":"Chow","year":"2020","journal-title":"N. Engl. J. Med."},{"issue":"Database issue","key":"10.1016\/j.plipres.2023.101242_bb1035","doi-asserted-by":"crossref","first-page":"D945","DOI":"10.1093\/nar\/gkq929","article-title":"COSMIC: mining complete cancer genomes in the Catalogue of Somatic Mutations in Cancer","volume":"39","author":"Forbes","year":"2011","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.plipres.2023.101242_bb1040","doi-asserted-by":"crossref","first-page":"5835","DOI":"10.1038\/ncomms6835","article-title":"Somatic mutations in arachidonic acid metabolism pathway genes enhance oral cancer post-treatment disease-free survival","volume":"5","author":"Biswas","year":"2014","journal-title":"Nat. Commun."},{"issue":"10","key":"10.1016\/j.plipres.2023.101242_bb1045","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1038\/sj.bjc.6603394","article-title":"11q13 amplification status and human papillomavirus in relation to p16 expression defines two distinct etiologies of head and neck tumours","volume":"95","author":"Ragin","year":"2006","journal-title":"Br. J. Cancer"},{"issue":"10","key":"10.1016\/j.plipres.2023.101242_bb1050","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1002\/cam4.499","article-title":"Clinical relevance of copy number profiling in oral and oropharyngeal squamous cell carcinoma","volume":"4","author":"van Kempen","year":"2015","journal-title":"Cancer Med."},{"issue":"1","key":"10.1016\/j.plipres.2023.101242_bb1055","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1002\/gcc.10048","article-title":"Mapping of nasopharyngeal carcinoma tumor-suppressive activity to a 1.8-megabase region of chromosome band 11q13","volume":"34","author":"Cheng","year":"2002","journal-title":"Genes Chromosom. Cancer"},{"issue":"11","key":"10.1016\/j.plipres.2023.101242_bb1060","doi-asserted-by":"crossref","DOI":"10.3390\/jcm8111896","article-title":"Comprehensive Genomic Review of TCGA Head and Neck Squamous Cell Carcinomas (HNSCC)","volume":"8","author":"Perez Sayans","year":"2019","journal-title":"J. Clin. Med."},{"issue":"4","key":"10.1016\/j.plipres.2023.101242_bb1065","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.trsl.2007.03.011","article-title":"Molecular classification of nodal metastasis in primary larynx squamous cell carcinoma","volume":"150","author":"Carinci","year":"2007","journal-title":"Transl. Res."},{"issue":"10","key":"10.1016\/j.plipres.2023.101242_bb1070","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1038\/ng.3090","article-title":"Genome-wide association study identifies three susceptibility loci for laryngeal squamous cell carcinoma in the Chinese population","volume":"46","author":"Wei","year":"2014","journal-title":"Nat. Genet."},{"issue":"Suppl. 1","key":"10.1016\/j.plipres.2023.101242_bb1075","first-page":"E783","article-title":"Immortalization of epithelial cells in oral carcinogenesis as revealed by genome-wide array comparative genomic hybridization: A meta-analysis","volume":"38","author":"Vincent-Chong","year":"2016","journal-title":"Head Neck"},{"issue":"7","key":"10.1016\/j.plipres.2023.101242_bb1080","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1002\/hed.21580","article-title":"Lean body mass gain in patients with head and neck squamous cell cancer treated perioperatively with a protein- and energy-dense nutritional supplement containing eicosapentaenoic acid","volume":"33","author":"Weed","year":"2011","journal-title":"Head Neck"},{"issue":"6","key":"10.1016\/j.plipres.2023.101242_bb1085","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13061206","article-title":"N-3 Long-Chain Polyunsaturated Fatty Acids, Eicosapentaenoic and Docosahexaenoic Acid, and the Role of Supplementation during Cancer Treatment: A Scoping Review of Current Clinical Evidence","volume":"13","author":"Newell","year":"2021","journal-title":"Cancers (Basel)"},{"issue":"11","key":"10.1016\/j.plipres.2023.101242_bb1090","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1634\/theoncologist.2018-0143","article-title":"Comparative molecular analyses of esophageal squamous cell carcinoma, esophageal adenocarcinoma, and gastric adenocarcinoma","volume":"23","author":"Salem","year":"2018","journal-title":"Oncologist"},{"issue":"10","key":"10.1016\/j.plipres.2023.101242_bb1095","first-page":"2980","article-title":"Amplification and expression of the human cyclin D gene in esophageal cancer","volume":"52","author":"Jiang","year":"1992","journal-title":"Cancer Res."},{"issue":"9","key":"10.1016\/j.plipres.2023.101242_bb1100","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1007\/s100380200065","article-title":"MYEOV, a gene at 11q13, is coamplified with CCND1, but epigenetically inactivated in a subset of esophageal squamous cell carcinomas","volume":"47","author":"Janssen","year":"2002","journal-title":"J. Hum. Genet."},{"issue":"1","key":"10.1016\/j.plipres.2023.101242_bb1105","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1111\/j.1349-7006.2006.00136.x","article-title":"Chemical genomic screening for methylation-silenced genes in gastric cancer cell lines using 5-aza-2'-deoxycytidine treatment and oligonucleotide microarray","volume":"97","author":"Yamashita","year":"2006","journal-title":"Cancer Sci."},{"issue":"51","key":"10.1016\/j.plipres.2023.101242_bb1110","doi-asserted-by":"crossref","first-page":"32433","DOI":"10.1073\/pnas.2006828117","article-title":"Polyunsaturated fatty acid biosynthesis pathway determines ferroptosis sensitivity in gastric cancer","volume":"117","author":"Lee","year":"2020","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"12","key":"10.1016\/j.plipres.2023.101242_bb1115","doi-asserted-by":"crossref","first-page":"5089","DOI":"10.7314\/APJCP.2015.16.12.5089","article-title":"Decreased Expression of FADS1 Predicts a Poor Prognosis in Patients with Esophageal Squamous Cell Carcinoma","volume":"16","author":"Du","year":"2015","journal-title":"Asian Pac. J. Cancer Prev."},{"issue":"5","key":"10.1016\/j.plipres.2023.101242_bb1120","first-page":"1553","article-title":"Heterogeneous genomic aberrations in esophageal squamous cell carcinoma: a review","volume":"12","author":"Li","year":"2020","journal-title":"Am. J. Transl. Res."},{"issue":"3","key":"10.1016\/j.plipres.2023.101242_bb1125","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1097\/SLA.0b013e31819a4789","article-title":"Enteral nutrition enriched with eicosapentaenoic acid (EPA) preserves lean body mass following esophageal cancer surgery: results of a double-blinded randomized controlled trial","volume":"249","author":"Ryan","year":"2009","journal-title":"Ann. Surg."},{"issue":"1","key":"10.1016\/j.plipres.2023.101242_bb1130","doi-asserted-by":"crossref","first-page":"4826","DOI":"10.1038\/s41598-017-05278-0","article-title":"Fish oil-enriched nutrition combined with systemic chemotherapy for gastrointestinal cancer patients with cancer cachexia","volume":"7","author":"Shirai","year":"2017","journal-title":"Sci. Rep."},{"issue":"13","key":"10.1016\/j.plipres.2023.101242_bb1135","doi-asserted-by":"crossref","first-page":"4428","DOI":"10.1158\/0008-5472.CAN-04-0431","article-title":"Genomic DNA-chip hybridization reveals a higher incidence of genomic amplifications in pancreatic cancer than conventional comparative genomic hybridization and leads to the identification of novel candidate genes","volume":"64","author":"Holzmann","year":"2004","journal-title":"Cancer Res."},{"key":"10.1016\/j.plipres.2023.101242_bb1140","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.pharmthera.2018.12.001","article-title":"New insights on the regulation of cancer cachexia by N-3 polyunsaturated fatty acids","volume":"196","author":"Gorjao","year":"2019","journal-title":"Pharmacol. Ther."},{"issue":"1","key":"10.1016\/j.plipres.2023.101242_bb1145","doi-asserted-by":"crossref","first-page":"3823","DOI":"10.1038\/s41598-018-21960-3","article-title":"Dietary n-3 and n-6 polyunsaturated fatty acids, the FADS gene, and the risk of gastric cancer in a Korean population","volume":"8","author":"Lee","year":"2018","journal-title":"Sci. Rep."},{"issue":"6","key":"10.1016\/j.plipres.2023.101242_bb1150","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1053\/j.gastro.2021.02.015","article-title":"Colorectal Cancer Incidence after Colonoscopy at Ages 45-49 or 50-54 Years","volume":"160","author":"Sehgal","year":"2021","journal-title":"Gastroenterology"},{"issue":"6","key":"10.1016\/j.plipres.2023.101242_bb1155","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1038\/ng.2985","article-title":"Large-scale genetic study in East Asians identifies six new loci associated with colorectal cancer risk","volume":"46","author":"Zhang","year":"2014","journal-title":"Nat. Genet."},{"issue":"9","key":"10.1016\/j.plipres.2023.101242_bb1160","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1158\/0008-5472.CAN-19-2389","article-title":"Risk SNP-Mediated Enhancer-Promoter Interaction Drives Colorectal Cancer through Both FADS2 and AP002754.2","volume":"80","author":"Tian","year":"2020","journal-title":"Cancer Res."},{"issue":"14","key":"10.1016\/j.plipres.2023.101242_bb1165","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1177\/1535370220929965","article-title":"CircFADS2: A potential prognostic biomarker of colorectal cancer","volume":"245","author":"Xiao","year":"2020","journal-title":"Exp. Biol. Med. (Maywood)"},{"key":"10.1016\/j.plipres.2023.101242_bb1170","doi-asserted-by":"crossref","first-page":"390","DOI":"10.3389\/fgene.2019.00390","article-title":"Circular RNAs and RNA Splice Variants as Biomarkers for Prognosis and Therapeutic Response in the Liquid Biopsies of Lung Cancer Patients","volume":"10","author":"de Fraipont","year":"2019","journal-title":"Front. Genet."},{"issue":"1","key":"10.1016\/j.plipres.2023.101242_bb1175","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.gene.2009.06.016","article-title":"Novel fatty acid desaturase 3 (FADS3) transcripts generated by alternative splicing","volume":"446","author":"Park","year":"2009","journal-title":"Gene"},{"issue":"8","key":"10.1016\/j.plipres.2023.101242_bb1180","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1194\/jlr.M025312","article-title":"A novel FADS1 isoform potentiates FADS2-mediated production of eicosanoid precursor fatty acids","volume":"53","author":"Park","year":"2012","journal-title":"J. Lipid Res."},{"issue":"5","key":"10.1016\/j.plipres.2023.101242_bb1185","doi-asserted-by":"crossref","first-page":"2403","DOI":"10.1007\/s11033-009-9750-9","article-title":"Alternative splicing generates a novel FADS2 alternative transcript in baboons","volume":"37","author":"Park","year":"2010","journal-title":"Mol. Biol. Rep."},{"issue":"4\u20136","key":"10.1016\/j.plipres.2023.101242_bb1190","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.plefa.2010.02.011","article-title":"Alternative transcripts of fatty acid desaturase (FADS) genes","volume":"82","author":"Brenna","year":"2010","journal-title":"Prostaglandins Leukot. Essent. Fat. Acids"},{"key":"10.1016\/j.plipres.2023.101242_bb1195","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.plefa.2018.06.004","article-title":"A novel FADS2 isoform identified in human milk fat globule suppresses FADS2 mediated Delta6-desaturation of omega-3 fatty acids","volume":"138","author":"Kothapalli","year":"2018","journal-title":"Prostaglandins Leukot. Essent. Fat. Acids"},{"issue":"12","key":"10.1016\/j.plipres.2023.101242_bb1200","doi-asserted-by":"crossref","first-page":"2279","DOI":"10.1194\/jlr.M019653","article-title":"The polypyrimidine tract binding protein regulates desaturase alternative splicing and PUFA composition","volume":"52","author":"Reardon","year":"2011","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.plipres.2023.101242_bb1205","doi-asserted-by":"crossref","DOI":"10.1016\/j.plefa.2020.102216","article-title":"Differences in erythrocyte phospholipid membrane long-chain polyunsaturated fatty acids and the prevalence of fatty acid desaturase genotype among African Americans and European Americans","volume":"164","author":"Rifkin","year":"2021","journal-title":"Prostaglandins Leukot. Essent. Fat. Acids"},{"issue":"1","key":"10.1016\/j.plipres.2023.101242_bb1215","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s004010000327","article-title":"Spatial variability of genomic aberrations in a large glioblastoma resection specimen","volume":"102","author":"Kros","year":"2001","journal-title":"Acta Neuropathol."},{"issue":"3","key":"10.1016\/j.plipres.2023.101242_bb1220","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1111\/j.1750-3639.1999.tb00532.x","article-title":"Amplification and expression of cyclin D genes (CCND1, CCND2 and CCND3) in human malignant gliomas","volume":"9","author":"Buschges","year":"1999","journal-title":"Brain Pathol."},{"issue":"5","key":"10.1016\/j.plipres.2023.101242_bb1225","doi-asserted-by":"crossref","DOI":"10.3390\/biom10050727","article-title":"Expression of SCD and FADS2 Is Lower in the Necrotic Core and Growing Tumor Area than in the Peritumoral Area of Glioblastoma Multiforme","volume":"10","author":"Korbecki","year":"2020","journal-title":"Biomolecules"},{"issue":"12","key":"10.1016\/j.plipres.2023.101242_bb1230","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1007\/BF02587914","article-title":"The fatty acid composition of human gliomas differs from that found in nonmalignant brain tissue","volume":"31","author":"Martin","year":"1996","journal-title":"Lipids"},{"issue":"4","key":"10.1016\/j.plipres.2023.101242_bb1235","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/j.plipres.2013.08.004","article-title":"Interaction of brain fatty acid-binding protein with the polyunsaturated fatty acid environment as a potential determinant of poor prognosis in malignant glioma","volume":"52","author":"Elsherbiny","year":"2013","journal-title":"Prog. Lipid Res."},{"issue":"1","key":"10.1016\/j.plipres.2023.101242_bb1240","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12937-016-0223-4","article-title":"Fish intake and the risk of brain tumor: a meta-analysis with systematic review","volume":"16","author":"Lian","year":"2017","journal-title":"Nutr. J."},{"key":"10.1016\/j.plipres.2023.101242_bb1245","author":"M.V. NCBI"}],"container-title":["Progress in Lipid Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163782723000322?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163782723000322?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,16]],"date-time":"2024-10-16T16:08:52Z","timestamp":1729094932000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163782723000322"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":247,"alternative-id":["S0163782723000322"],"URL":"https:\/\/doi.org\/10.1016\/j.plipres.2023.101242","relation":{},"ISSN":["0163-7827"],"issn-type":[{"value":"0163-7827","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"FADS2 function at the major cancer hotspot 11q13 locus alters fatty acid metabolism in cancer","name":"articletitle","label":"Article Title"},{"value":"Progress in Lipid Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.plipres.2023.101242","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101242"}}